Lexeo Therapeutics (LXEO) CAPEX

Annual CAPEX

N/A

December 31, 2023

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

LXEO CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$901.00 K
LXEO annual capital expenditures is currently at an all-time high

3-Year Low

$188.00 K
LXEO annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
LXEO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 11, 2025
LXEO next annual earnings announcement is scheduled for Mar 11, 2025

OtherLXEOcash flowmetrics:

Annual FCF

-$59.66 M
LXEO annual free cash flow is -$59.66 million

Annual CFO

-$59.50 M
LXEO annual cash flow from operations is -$59.50 million

Annual CFI

-$165.00 K
LXEO annual cash flow from investing activities is -$165.00 thousand

Annual CFF

$103.79 M
LXEO annual cash flow from financing activities is $103.79 million

Quarterly CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

LXEO Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$794.00 K
LXEO quarterly capital expenditures is currently at an all-time high

3-Year Low

$394.00 K
LXEO quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LXEO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 11, 2025
LXEO next earnings announcement is scheduled for Mar 11, 2025

OtherLXEOcash flowmetrics:

Quarterly FCF

-$17.89 M
LXEO quarterly free cash flow is -$17.89 million

Quarterly CFO

-$17.81 M
LXEO quarterly cash flow from operations is -$17.81 million

Quarterly CFI

-$83.00 K
LXEO quarterly cash flow from investing activities is -$83.00 thousand

Quarterly CFF

-$72.00 K
LXEO quarterly cash flow from financing activities is -$72.00 thousand

TTM CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

LXEO TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.19 M
LXEO TTM capital expenditures is currently at an all-time high

3-Year Low

$394.00 K
LXEO TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LXEO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 11, 2025
LXEO next earnings announcement is scheduled for Mar 11, 2025

OtherLXEOcash flowmetrics:

TTM FCF

-$67.37 M
LXEO TTM free cash flow is -$67.37 million

TTM CFO

-$66.81 M
LXEO TTM cash flow from operations is -$66.81 million

TTM CFI

-$567.00 K
LXEO TTM cash flow from investing activities is -$567.00 thousand

TTM CFF

$188.94 M
LXEO TTM cash flow from financing activities is $188.94 million

LXEO CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

LXEO CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

Lexeo Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Dec 2022
$901.00 K
-
-
Sep 2022
-
$794.00 K(+101.5%)
$1.19 M(+201.5%)
DateAnnualQuarterlyTTM
Jun 2022
-
$394.00 K
$394.00 K
Dec 2021
$188.00 K
-
-

FAQ

  • What is the all time high annual CAPEX for Lexeo Therapeutics?
  • What is the all time high quarterly CAPEX for Lexeo Therapeutics?
  • What is the all time high TTM CAPEX for Lexeo Therapeutics?

What is the all time high annual CAPEX for Lexeo Therapeutics?

Lexeo Therapeutics all-time high annual capital expenditures is $901.00 K

What is the all time high quarterly CAPEX for Lexeo Therapeutics?

Lexeo Therapeutics all-time high quarterly capital expenditures is $794.00 K

What is the all time high TTM CAPEX for Lexeo Therapeutics?

Lexeo Therapeutics all-time high TTM capital expenditures is $1.19 M